Flow injection chemiluminescence determination of lercanidipine based on N-chlorosuccinimide-eosin Y post-chemiluminescence reaction

Luminescence. 2014 Dec;29(8):1008-13. doi: 10.1002/bio.2651. Epub 2014 Feb 24.

Abstract

A novel post-chemiluminescence (PCL) reaction was discovered when lercanidipine was injected into the CL reaction mixture of N-chlorosuccinimide with alkaline eosin Y in the presence of cetyltrimethylammonium bromide (CTAB), where eosin Y was used as the CL reagent and CTAB as the surfactant. Based on this observation, a simple and highly sensitive PCL method combined with a flow injection (FI) technique was developed for the assay of lercanidipine. Under optimum conditions, the CL signal was linearly related to the concentration of lercanidipine in the range 7.0 × 10(-10) to 3.0 × 10(-6) g/mL with a detection limit of 2.3 × 10(-10) g/mL (3σ). The relative standard deviation (RSD) was 2.1% for 1.0 × 10(-8) g/mL lercanidipine (n = 13). The proposed method had been applied to the estimation of lercanidipine in tablets and human serum samples with satisfactory results. The possible CL mechanism is also discussed briefly.

Keywords: N-chlorosuccinimide; eosin Y; flow injection; lercanidipine; post chemiluminescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Artifacts
  • Cetrimonium
  • Cetrimonium Compounds / chemistry
  • Dihydropyridines / administration & dosage
  • Dihydropyridines / analysis*
  • Dihydropyridines / blood
  • Eosine Yellowish-(YS) / chemistry*
  • Flow Injection Analysis / methods
  • Fluorescent Dyes / chemistry
  • Humans
  • Kinetics
  • Limit of Detection
  • Luminescent Measurements / methods*
  • Sodium Hydroxide / chemistry
  • Succinimides / chemistry*
  • Surface-Active Agents / chemistry
  • Tablets / analysis

Substances

  • Cetrimonium Compounds
  • Dihydropyridines
  • Fluorescent Dyes
  • Succinimides
  • Surface-Active Agents
  • Tablets
  • N-chlorosuccinimide
  • Sodium Hydroxide
  • Eosine Yellowish-(YS)
  • lercanidipine
  • Cetrimonium